Stock Analiz

Aardvark Therapeutics, Inc. (AARD) stock forecast and price target

Price $1.33 · data as of November 13, 2026

12-month price target

Average target$4.57
Upside / downside+243.7%
Analysts7
ConsensusHold
Low $1.50Average $4.57High $10.00

Gold marker: average target · white marker: today’s price ($1.33)

Analyst ratings

Strong buy 0Buy 4Hold 5Sell 1Strong sell 1

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$-3.27−11.6%$0
Next fiscal year
ends December 31, 2027
$-2.52+22.8%$0
Next quarter
ends December 31, 2026
$-0.75+7.4%$0
Quarter after
ends March 31, 2027
$-0.64+35.1%$0

Consensus of the analysts covering Aardvark Therapeutics, updated daily. In the last 30 days 2 estimates were raised and 0 lowered.

Frequently asked questions

What is the Aardvark Therapeutics stock price target?

The average 12-month target from 7 analysts is $4.57, 243.7% above the current price of $1.33 Targets range from $1.50 to $10.00.

Is Aardvark Therapeutics a buy according to analysts?

The consensus rating is “Hold” (4 buy, 5 hold, 1 sell, 1 strong sell). Ratings are opinions, not guarantees; this is not investment advice.

How much is Aardvark Therapeutics expected to earn?

Analysts expect EPS of $-3.27 for the fiscal year ending December 31, 2026 and $-2.52 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.